| Line Item | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development (including non-cash stock-based compensation expense of $0.9 million and $0.6 million for three months ended June 30, 2026 and 2025, respectively and $1.8 million and $1.1 million for six months ended June 30, 2026 and 2025 respectively) | ||||
| General and administrative (including non-cash stock-based compensation expense of $36.0 million and $1.2 million for the three months ended June 30, 2026 and 2025, respectively and $37.6 million and $2.3 million for six months ended June 30, 2026 and 2025 respectively | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income (expense), net | ||||
| Interest income, net | ||||
| Research and development tax credit | ||||
| Other expense, net | ||||
| Total other income, net | ||||
| Loss before income taxes | ||||
| Income tax provision | ||||
| Net loss | ||||
| Net loss per share, basic | ||||
| Net loss per share, diluted |